Genome-Wide Transcriptome Analysis of CD36 Overexpression in HepG2.2.15 Cells to Explore Its Regulatory Role in Metabolism and the Hepatitis B Virus Life Cycle by Huang, J et al.
RESEARCH ARTICLE
Genome-Wide Transcriptome Analysis of
CD36 Overexpression in HepG2.2.15 Cells to
Explore Its Regulatory Role in Metabolism
and the Hepatitis B Virus Life Cycle
Jian Huang1, Lei Zhao1, Ping Yang1, Zhen Chen1, Ni Tang1, Xiong Z. Ruan1,2, Yaxi Chen1*
1 Centre for Lipid Research & Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of
Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital,
Chongqing Medical University, Chongqing, China, 2 John Moorhead Research Laboratory, Centre for




Hepatitis B virus (HBV) is a hepatocyte-specific DNA virus whose gene expression and rep-
lication are closely associated with hepatic metabolic processes. Thus, a potential anti-viral
strategy is to target the host metabolic factors necessary for HBV gene expression and rep-
lication. Recent studies revealed that fatty acid translocase CD36 is involved in the replica-
tion, assembly, storage, and secretion of certain viruses, such as hepatitis C virus (HCV)
and human immunodeficiency virus (HIV). However, the relationship between CD36 and
the HBV life cycle remains unclear. Here, we showed, for the first time, that increased
CD36 expression enhances HBV replication in HepG2.2.15 cells. To understand the under-
lying molecular basis, we performed genome-wide sequencing of the mRNA from
HepG2.2.15-CD36 overexpression (CD36OE) cells and HepG2.2.15-vector cells using
RNA Sequencing (RNA-seq) technology to analyze the differential transcriptomic profile.
Our results identified 141 differentially expressed genes (DEGs) related to CD36 overex-
pression, including 79 upregulated genes and 62 downregulated genes. Gene ontology
and KEGG pathway analysis revealed that some of the DEGs were involved in various met-
abolic processes and the HBV life cycle. The reliability of the RNA-Seq data was confirmed
by qPCR analysis. Our findings provide clues to build a link between CD36, host metabo-
lism and the HBV life cycle and identified areas that require further investigation.
Introduction
Hepatitis B virus (HBV) infection is a major cause of morbidity and mortality around the world
because it enhances the development of hepatitis, cirrhosis and hepatocellular carcinoma [1].
HBV is a small liver-specific targeting DNA virus. It consists of partially double-strandedDNA
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that can be bound with a variety of cellular transcription factors to regulate viral gene expres-
sion, some of which are activators of hepatic genes related to metabolism, for example, glucose
and lipid synthesis and consumption[2].Therefore, HBV is designated as a “metabolovirus” due
to the unique interaction between the virus and host metabolic processes in the liver [3]. A
potential antiviral strategy is to target the host factors necessary for HBV gene expression.
Cluster of differentiation 36 (CD36), also known as fatty acid translocase, is a transmem-
brane glycoprotein that is widely expressed in various tissues, including the liver, heart, muscle
and adipose tissue[4]. It is mainly involved in the metabolism of fatty acids, including the uptake
of long-chain fatty acids (LCFA), accumulation of lipids and somemetabolic dysfunctions
under the conditions of excessive fatty acid supply[5]. In addition to LCFA, CD36 can recognize
lipid ligands, such as oxidized phospholipids and cholesterol, and its binding behavior can initi-
ate signal transduction in many cells. Because of these signal transduction capabilities, CD36 is
involved in inflammation, immune response, angiogenesis, atherogenesis and thrombosis[6].
We do not yet fully understand the roles of CD36 in human liver diseases, but significant prog-
ress has been recently made. A study found that CD36 contributed to HCV replication by facili-
tating viral attachment on the host cell membrane and CD36 inhibitors blockedHCV
replication in vitro [7]. Recent studies have revealed that CD36 silencing in human immunode-
ficiency virus (HIV)-infectedmacrophages showed decreased amount of virions released, which
could also be inhibited by soluble anti-CD36 antibodies. The transmission of virus to CD4+ T
cells was also influenced [8]. These results suggest that CD36 is required for the HCV and HIV
life cycle. Thus, CD36 could be a potential drug target against HCV and HIV.
Many studies have found that CD36 is involved in lipid metabolism disorder, such as meta-
bolic syndrome (MS), nonalcoholic fatty liver disease (NAFLD) [9, 10]. A population-based
study demonstrated that patients with MS had increasedHBV DNA loads compared with
those without MS [11]. However, whether CD36 is involved in HBV replication is still unclear.
We preliminarily demonstrated that the expression of CD36 was increased in HBV-expressing
cell line, suggesting a possible function of CD36 in modulatingHBV replication. Here, the
HepG2.2.15 cell line, which supports HBV stable replication, protein expression, and virion
assembly and secretion [12], was employed as a model to further investigate the relationship
among CD36, the HBV life cycle and host metabolism.We first showed that CD36 overexpres-
sion could enhance HBV replication in HepG2.2.15 cells. To uncover the potential role of
CD36 in the HBV life cycle, a comparative transcription analysis was performed in
HepG2.2.15-CD36 overexpression (CD36OE) and HepG2.2.15-vector stable cell lines using
RNA-seq technology to detect the differential transcriptomic profile. The goal of this study was
to identify differentially expressed genes (DEGs) betweenHepG2.2.15-CD36OE and
HepG2.2.15-vector cells to improve the understanding of the molecularmechanism associated
with increased CD36 expression in HBV replication cell lines. The main function of the DEGs
was analyzed by gene ontology and pathway analysis. Then, gene co-expression networks were
constructed to identify the interactions among the DEGs. In addition, real-time PCR was per-
formed to validate the expression changes of the DEGs involved in CD36 overexpression.
Methods
Cells culture and construction
Human hepatocellular carcinoma cell line HepG2 and HepG2.2.15 cells (stably HBV trans-
fectedHepG2 cells, as well as expression of virus related proteins) (preserved in Chongqing
Key Laboratory of Molecular Biology for Infectious Diseases) were maintained with modified
Eagle’s medium (MEM) containing 10% fetal calf serum, and HepG2.2.15 cells required addi-
tional 500 μg G418/mL. To generate HepG2.2.15 cells that could stably overexpress CD36,
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human CD36 cDNA was cloned into the GV341 plasmid. Next, a lentivirus-CD36 overexpres-
sion system was constructed, packaged, and purified by GeneChem.CD36-overexpression-len-
tivirus and vector-lentivirus were transfected into HepG2.2.15 cells and were designated as
HepG2.2.15-CD36OE and HepG2.2.15-vector cells, respectively. Subsequently, puromycin
(2 μg/mL) was used to select stably transfected cell lines.
Western blotting
To identify CD36 expression in HepG2, HepG2.2.15, HepG2.2.15-CD36OE and HepG2.2.15--
vector cells, cells were lysed using RIPA containing a protease inhibitor cocktail (Roche, Ger-
many), and the protein concentration was measured and normalized for western blotting.
Proteins (50 μg) were separated by 8% SDS-PAGE gradient gels and transferred onto PVDF
membranes. After blocking with 3% BSA, membranes were incubated with antibody against
human CD36 (Abcam, UK) at 4°C overnight. The membranes were then incubated with the
corresponding secondary peroxidase-coupled antibody. Finally, the detection procedure was
performed using an ECL Advance Western Blotting Detection kit (Millipore, USA). Densito-
metric analysis was performed using Image J software (National Institutes of Health,USA). An
anti-β-actin antibody was used as a loading control.
Southern blot analysis
Core particles associated with HBV DNA replicative intermediates were extracted from
HepG2.2.15-CD36OE and HepG2.2.15-vector cells after 96 hours, according to the previously
describedmethod[13]. HBV DNA samples were separated by electrophoresis in 1% agarose gel
and transferred onto nylon membranes. UV cross-linking, prehybridization, and hybridization
were performed according to the protocol from the manufacturer of the DIG-High Prime
DNA Labeling and Detection Starter Kit I (Roche, Germany). The signal was detected by expo-
sure on an X-ray film.
Quantification and differential expression analysis of transcripts
Total RNA was extracted using TRIzol reagent (Invitrogen, USA) according to the protocol
provided by the manufacturer, after which the concentration was measured by a NanoDrop
2000 (Thermo Scientific,USA) with the quality assessed by an Agilent 2200 (Agilent, USA).
An RNA sequencing library of each sample was prepared using the Ion Total RNA-Seq Kit v2,
in accordance with the protocol provided by the manufacturer (Life technologies,USA). After
library construction, each library preparation was sequenced using the Ion PI™ chip, and the
raw reads were generated. After filtering, the clean reads were used to map to the reference
genome usingMisplacing software[14]. The expression level of each gene was normalized by
the reads per kilobase per million (RPKM) [15]. To identify DEGs, the DEseq package was
used to filter the DEGs for the HepG2.2.15-CD36OE and HepG2.2.15-vector groups[16]. After
the statistical analysis, we screened the DEGs with a fold change> 1.5 or fold change< 0.667,
and the false discovery rate (FDR) threshold was FDR< 0.05.
Gene ontology and pathway analysis
To identify the main function of the DEGs, gene ontology (GO) analysis was performedusing
the GO-TermFinder tool [17]. Significantly enrichedGO terms were detected according to a p-
value< 0.05. Moreover, to identify the significantly enriched pathways, pathway annotation was
performed according to the KEGG database [18]. The significantly enriched pathways were com-
puted on the basis of the Fisher test of the hyper geometric distribution at a p-value< 0.05.
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Co-expression network analysis
All DEGs were used to construct gene co-expression networks on the basis of the normalized
signal intensity of specific genes. The Pearson’s correlation of each pair of genes was computed,
and the significantly correlated pairs were selected to construct the co-expression network
[19]. The centrality degree of a gene was assigned in terms of the number of links that one
node has with another [20, 21]. The centrality degree represents the centrality of genes in the
network and can reflect the relative importance of the gene. In addition, the k-cores were
adopted so that all nodes are connected to at least k other genes in the subnetwork [22]. Within
the networks analysis, firstly, the DEGs with the highest difference centrality degree (absolute
value6) were selected; secondly, among above screening genes, the genes with the highest dif-
ference k-core scoring (absolute value6) were recognized as potential core regulatory genes.
Quantitative real-time PCR validation
To identify CD36 overexpression, the total RNA of HepG2.2.15-CD36OE and HepG2.2.15--
vector cells was extracted and reverse-transcribed to cDNA for quantification by real-time
PCR. To validate the RNA-Seq results, cDNA was synthesized using 1 μg of the original RNA
sample by reverse transcription according to the protocol, and these cDNA templates were
used for further quantitative PCR analysis. Quantitative real-time PCR (qPCR) using the SYBR
Green method was used to detect the gene expression level. β-actin was chosen as the reference
gene, and the expression levels were computed according to the 2−ΔΔCt values. The primer
sequences are provided in S1 Table.
Results
CD36 overexpression enhanced HBV replication in HepG2.2.15 cells
To identify a potential relationship betweenHBV replication and CD36, we firstly examined
the expression of CD36 in HepG2.2.15 and its parental HepG2 cells. As compared with HepG2
cells, the protein level of CD36 was significantly upregulated in HepG2.2.15 cells (S1 Fig). The
results revealed that CD36 was significantly upregulated by HBV replication, suggesting that
CD36 might play a role in HBV replication. To further understand the relationship between
CD36 and HBV, we constructedCD36 overexpression cell lines in HepG2.2.15 cells using the
lentivirus-CD36 overexpression system. Our results showed that the CD36 mRNA and protein
levels were significantly higher in the HepG2.2.15-CD36OE group than in the HepG2.2.15--
Vector group (Fig 1A and 1B), suggesting that the cell model of CD36 overexpression was suc-
cessfully established. Next, HBV DNA replicative intermediates were detected by both qPCR
and Southern blotting. The data showed that upregulation of CD36 resulted in enhanced levels
of HBV DNA in HepG2.2.15 cells (Fig 1C and 1D).
RNA-seq of the HepG2.2.15-CD36OE and HepG2.2.15-vector cell
transcriptome
To better understand the molecular changes in response to CD36 overexpression in
HepG2.2.15 cells, three cDNA libraries fromHepG2.2.15-vector cells (Vector-1, Vector-2, and
Vector-3) and HepG2.2.15-CD36OE cells (CD36OE-1, CD36OE-2, and CD36OE-3) were con-
structed. After performing quality control, an Ion ProtonTM Sequencerwas used to sequence
the cDNA libraries. High-throughput sequencing yielded 15.30, 14.68, and 17.46 and 13.74,
14.37, and 18.87 million total raw reads fromHepG2.2.15-vector cells and HepG2.2.15-C-
D36OE cells (S2 Table), respectively. After filtering the raw reads, 14.34, 13.71, and 16.13 and
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12.99, 13.54, and 17.50 million clean reads were obtained.More than 92% of the filtered reads
were used for downstream analysis.
To further analyze the gene expression profile, the clean reads in the six libraries were com-
pared to the human reference genome using the MapSplice tool. The results showed that the
proportions of clean reads (90.9%, 91.3%, and 90.7% and 93.4%, 92%, and 90.7% in the
HepG2.2.15-vector and HepG2.2.15-CD36OE cell libraries, respectively)matched the human
reference genome (Table 1). Moreover, some of these clean reads were uniquely mapped to the
reference genome: 12.49 (87.1%), 12.00 (87.6%), and 14.07 (87.2%) million reads in the
HepG2.2.15-vector libraries and 11.66 (89.8%), 11.95 (88.2%), and 15.22 (86.9%) million reads
in the HepG2.2.15-CD36OE libraries.
Analysis of gene differential expression
To identify the DEGs, the number of unique clean reads for each gene was computed and nor-
malized to RPKM. The RPKM distribution showed there were few different genes in the same
groups (S2 Fig). The criteria of fold change> 1.5 or fold change< 0.667 in expression and
Fig 1. CD36 overexpression enhanced HBV replication in HepG2.2.15 cells. (A and B) The mRNA and
protein levels of CD36 were analyzed in HepG2.2.15 cells with the stable overexpression of CD36. (C and D)
HBV replication was enhanced in HepG2.2.15 cells with stable overexpression of CD36 compared with the
vector control. Core particles associated with HBV intermediates were extracted after 4 days and were
identified by qPCR (C) and Southern blotting (D). The values are presented as the means± SD (n3).
Comparisons among groups were determined with independent-sample t-test using the SPSS software
(Version 11.5). Significant differences are considered at *P<0.05 and *** p < 0.0001 versus control group.
doi:10.1371/journal.pone.0164787.g001
The Relationship between Fatty Acid Translocase CD36 and the Hepatitis B Virus
PLOS ONE | DOI:10.1371/journal.pone.0164787 October 17, 2016 5 / 15
FDR< 0.05 were chose to screen the significantly upregulated or downregulated genes. A total
of 141 DEGs were identified according to these criteria, including 79 upregulated genes and 62
downregulated genes (S3 Table). Some genes associated with HIV were also found in this anal-
ysis, including apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B),
C-Cmotif chemokine ligand 20(CCL20), PDZ domain containing 8(PDZD8), and beta-site
APP-cleaving enzyme 2(BACE2). Together, our results demonstrated that there were distinct
gene regulation patterns between the HepG2.2.15-CD36OE group and the HepG2.2.15-vector
group, suggesting that CD36 overexpression can produce unique gene profiles, which may be
related to the HBV life cycle.
Functional annotation of differentially expressed genes
To understand the functions of the DEGs, GO analysis was carried out. According to the GO
terms, 66, 74, and 64 DEGs were classified into biological processes, molecular functions and
cellular components, respectively. Compared to the HepG2.2.15-vector group, the highly
enrichedGO terms of biological processes in the HepG2.2.15-CD36OE group were related to
positive regulation of macrophage-derived foam cell differentiation, positive regulation of cho-
lesterol storage, low-density lipoprotein particle clearance, cellular response to lipoteichoic
acid, and low-density lipoprotein particle remodeling (Fig 2A). In the category of molecular
function, the most significant subcategories were lipoteichoic acid receptor activity, ATP-acti-
vated inward rectifier potassium channel activity, thrombospondin receptor activity, thiamine
pyrophosphate binding, and protein binding (Fig 2B). The main subcategories of the cellular
component were extracellular space, extracellular region, extracellular vesicular exosome, and
small ribosomal subunit (Fig 2C). These results showed that CD36 overexpression was mainly
involved in the regulation of lipid metabolic process, lipoprotein transport, translation and
viral process. Three genes of ribosomal protein S25(RPS25), ribosomal protein L10(RPL10)
and ribosomal protein S28(RPS28) contribute to the GO terms of viral transcription and the
viral life cycle.Furthermore, to understand the functional relationships of the GO terms, GO
trees were constructed (Fig 3). As shown in Fig 3, the genes in the HepG2.2.15-CD36OE
groups were highly enriched in categories related to long-chain fatty acid transport, plasma
lipoprotein particle clearance carboxylic metabolic processes, translation, RNA metabolic
Table 1. Summary of RNA-seq data mapped to the reference genome.
Sample name Vector-1 Vector-2 Vector-3 CD36OE-1 CD36OE-1 CD36OE-1
Allreads 14335354 13706017 16130270 12993601 13543156 17500321
UnMapped 1304643 1198305 1495013 860501 1083308 1631453
Mapped 13030711 12507712 14635257 12133100 12459848 15868868
MappedRate 90.9% 91.3% 90.7% 93.4% 92.0% 90.7%
UniqueMapped 12489663 12004214 14067500 11661802 11947415 15216321
UniqueMappedRate 87.1% 87.6% 87.2% 89.8% 88.2% 86.9%
RepeatMapped 541048 503498 567757 471298 512433 652547
JunctionAllMapped 4345060 4295847 4926564 4381305 4262410 5307358
JunctionUniqueMapped 4338301 4289175 4919678 4369591 4253552 5299893
AllBase 2183679165 2083371812 2481865449 2080596567 2151759352 2721359004
UnMappedBase 156007543 141200940 176569476 103653653 130614823 188418418
MappedBase 2027671622 1942170872 2305295973 1976942914 2021144529 2532940586
UniqueMappedBase 1949440314 1870217136 2222958444 1906932384 1944226993 2438795965
RepeatMappedBase 78231308 71953736 82337529 70010530 76917536 94144621
doi:10.1371/journal.pone.0164787.t001
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processes, mRNA transcription, positive regulation of cytokine biosynthetic process and ribo-
somal small subunit biogenesis compared to the HepG2.2.15-vector group. These GO enrich-
ment categories provide clues about the role of CD36 in HBV replication cell lines, which will
facilitate screening of the genes that contribute to these categories.
Fig 2. Gene Ontology analysis of the differentially expressed genes. The GO categories include biological processes, molecular functions and
cellular components, respectively.
doi:10.1371/journal.pone.0164787.g002
Fig 3. GO trees of the GO terms. Red indicates the GO terms of the upregulated genes, green indicates the GO terms of
the downregulated genes, and yellow indicates the GO terms from both upregulated and downregulated genes.
doi:10.1371/journal.pone.0164787.g003
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KEGG enrichment analysis was performed to further investigate the potential function of
these DEGs. These 141 DEGs were mapped to 56 pathways. Ultimately, five statistically signifi-
cant enrichment pathways were identified according to the hypergeometric test (p< 0.05).
These pathways were involved in fat digestion and absorption, tryptophanmetabolism, arachi-
donic acid metabolism, ribosomes, and gastric acid secretion (Table 2).
Co-expressed genes and their networks
Furthermore, we constructed general co-expression networks of DEGs to identify the core
genes accompanying CD36 overexpression. In the HepG2.2.15-vector group, the co-expression
network had a total of 496 connections between genes (Fig 4). Within this co-expression net-
work, 254 pairs presented as positive and 242 pairs presented as negative. In the
HepG2.2.15-CD36OE group, the co-expression network showed a total of 516 connections
between genes (Fig 5). Within this co-expression network, 269 pairs presented as positive and
247 pairs presented as negative. The networks showed that there were markedly different pat-
terns of gene co-expression in the two groups. Total 11 genes were selected as potential core
regulatory genes according to the highest difference centrality degree and highest difference k-
core scoring (Table 3). Furthermore, according to GO analysis, we found that the functions of
some core genes were related to deoxycytidine deaminase activity, calmodulin binding, epider-
mal growth factor receptor binding, structuralmolecule activity, cation transmembrane trans-
porter activity.
Confirmation of differentially expressed genes by quantitative real-time
PCR
To validate the expression levels of the DEGs, 11 DEGs were randomly selected for validation
by qPCR. As shown in Fig 6, the qPCR results of the DEGs were in agreement with those of the
RNA-Seq analysis, suggesting the RNA-Seq data used in the present study was reliable and
accurate.
Discussion
In this study, we first reported that the CD36 protein levels were significantly higher in the
HepG2.2.15 cells than in its parental HepG2 cells. Further results demonstrated that CD36
overexpression could significantly enhance HBV replication in HepG2.2.15 cell lines. To reveal
the potential molecularmechanism, we performed genome-wide analysis of mRNAs from
HepG2.2.15-vector cells and HepG2.2.15-CD36OE cells to detect DEGs involved in metabo-
lism and the HBV life cycle. To our knowledge, this is the first genome-wide analysis of
mRNAs to screen DEGs that were induced by increasing CD36 expression. Therefore, we pro-
pose that these data will serve as a powerful tool and resource for future research related to the
effects of CD36 on host metabolism and the HBV life cycle.
Table 2. The significantly statistical enrichment pathways of differentially expressed genes.
Pathway ID Pathway Term Pathway gene P-Value Enrichment (-log2P)
PATH:04975 Fat digestion and absorption APOB,PLA2G2A 0.0007104 20.075099 10.459042
PATH:00380 Tryptophan metabolism OGDHL,DDC 0.0102091 14.658009 6.6139949
PATH:03010 Ribosome RPS28, RPS25,RPL10 0.0128876 6.840404 6.2778757
PATH:00590 Arachidonic acid metabolism GPX2, PLA2G2A 0.0244863 9.0534759 5.3518817
PATH:04971 Gastric acid secretion KCNJ10, KCNK10 0.0291768 8.2084848 5.0990353
doi:10.1371/journal.pone.0164787.t002
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The RNA-Seq results identified 141 DEGs. Among these DEGs, some virus-related genes
were differentially regulated between the two cell lines, includingAPOBEC3B,CCL20, PDZD8,
and BACE2, which are known to be associated with the HIV-1 virus life cycle or to interact
with HIV-1 proteins[23–26]. Whether these DEGs were participants in the HBV life cycle
requires further investigation. Moreover, through GO and GO tree analysis, we also identified
some unregulated genes that were involved in viral transcription and viral life cycle, such as
RPS25 and RPL10 [27, 28]. Because the HBV replication requires an obligatory reverse tran-
scription step, the results imply that CD36 may modulate HBV transcription. For further
exploration of CD36-specific genes, we established co-expression networks in the
HepG2.2.15-CD36OE and HepG2.2.15-vector groups for DEGs according to the Pearson’s cor-
relation of each pair of genes. Gene co-expression network analysis is a powerfulmethod to
explore the intrinsic organization of a transcriptome[29]. According to the co-expression net-
works of the DEGs, we identified the core genes accompanying CD36 overexpression. Among
the “key regulatory” genes, we specially focused on the expression levels of APOBEC3B. A
series of studies reported that APOBEC3B could edit HBV covalently closed circular DNA
(cccDNA) and reduce HBV replication in vitro and in vivo [30]. In addition, Interferon-α
treatment could upregulate the expression of APOBEC3B to induce cccDNA degradation [31].
Upon infection, the cccDNA serves as the template for HBV viral transcription and replication
Fig 4. Gene co-expression network analysis for the HepG2.2.15-vector group. The lines represent regulatory
relationships: solid lines indicate positive correlations; dashed lines indicate negative correlations. The volume of the
node represents the degree centrality of co-expression, the color represents the “k-core” scores.
doi:10.1371/journal.pone.0164787.g004
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[32]. Point mutations inactivatingAPOBEC3B reduced the inhibitory activity on HBV replica-
tion to approximately 40% [33]. Our data demonstrated that CD36 overexpression could
inhabit the expression of APOBEC3B, suggesting that CD36 overexpression may increase HBV
replication by inhabited APOBEC3B.
Fig 5. Gene co-expression network analysis for the HepG2.2.15-CD36OE group. The lines represent regulatory
relationships: solid lines indicate positive correlations; dashed lines indicate negative correlations. The volume of the
node represents the degree centrality of co-expression, the color represents the “k-core” scores.
doi:10.1371/journal.pone.0164787.g005
Table 3. Core genes between the co-expression networks of HepG2.2.15-CD36OE and HepG2.2.15-vector.












IGDCC3 15 4 10 4 11 6
NRGN 16 5 10 4 11 6
EREG 15 5 9 3 10 6
KRT75 16 7 10 4 9 6
SLC30A7 11 3 9 3 8 6
APOBEC3B 9 1 7 1 8 6
LINC00263 6 12 4 10 -6 -6
LOC100287868 4 12 3 9 -8 -6
NBPF11 4 12 3 9 -8 -6
MTRNR2L6 5 14 4 10 -9 -6
HEPACAM 4 12 3 10 -8 -7
doi:10.1371/journal.pone.0164787.t003
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In addition, we also identifiedmany other genes that were significantly differentially regu-
lated between the two cell lines involved in host metabolism. According to the KEGG pathway
analysis, CD36 overexpression mainly affected the pathways of fat digestion and absorption,
tryptophanmetabolism, arachidonic acid metabolism, ribosomes, and gastric acid secretion.
Furthermore, the apolipoprotein B (APOB) gene was significantly downregulated and phos-
pholipase A2 group IIA (PLA2G2A) was significantly upregulated in the fat digestion and
absorption pathway in the present study. A previous study suggested that CD36 could regulate
the release of arachidonic acid (AA) from cellular membranes by activating cytoplasmic phos-
pholipase A2, which contributes to the production of proinflammatory eicosanoids[34]. The
downregulated genes oxoglutarate dehydrogenase-like (OGDHL) and dopa decarboxylase
(DDC) were involved in tryptophanmetabolism. A ribosome is an organelle that translates
messenger RNA into a polypeptide chain in the course of protein synthesis. Ribosomal proteins
play important roles in the regulation of transcription, DNA repair, cell proliferation and apo-
ptosis. In the present study, some significant DEGs involved in ribosome pathways were upre-
gulated. Thus, we inferred that the ribosome pathway is an important process that is affected
by CD36. Previous studies reported that CD36 was involved in store-operated calcium flux
[34]. Among the DEGs, we found that neurogranin (NRGN) was related to calcium signaling.
Neurogranin is a member of the IQ motif class of calmodulin-bindingproteins, which can be
bound to the C-terminal domain of calmodulin to increase the Ca2+ dissociation rate [35]. Cal-
cium signaling is a key factor in HBV and is involved in HBV DNA replication and HBV core
assembly [36–39]. Therefore, CD36 may regulate the HBV life cycle through calcium signaling.
In addition to calcium homeostasis, KEGG pathway analysis showed that the genes of potas-
sium voltage-gated channel subfamily J member 10(KCNJ10) and potassium two pore domain
channel subfamily K member 10(KCNK10) contributes to the GO terms of gastric acid secre-
tion.KCNJ10 gene encodes a member of the inward rectifier-type potassium channel family,
which allows K+ flow into the cell [40]. KCNK10 channel is an open rectifierwhich primarily
passes outward current under physiological K+ concentrations [41]. In the present study, the
Fig 6. Validation of the RNA-Seq results using quantitative real-time PCR. The values are presented as the means±SD (n = 4).
Comparisons among groups were determined with independent-sample t-test using the SPSS software (Version 11.5). Significant differences
are considered at *P<0.05, ** p < 0.001 and *** p < 0.0001 versus control group.β-actin was used as the reference gene.
doi:10.1371/journal.pone.0164787.g006
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KCNJ10 was significantly upregulated and KCNK10 was significantly downregulated, which
could lead to increase cytoplasm concentration of potassium ion. Our results suggest that
CD36 is involved in K+ homeostasis in the liver cells. Whether KCNK10 and KCNJ10 channel
are participants in the HBV life cycle needs to be further investigation.
In conclusion, we reported, for the first time, that increasing the expression of CD36 could
promote HBV replication in HepG2.2.15 cells. To understand the role of enhanced CD36
expression in host metabolism and the HBV life cycle in HBV replication cell lines, we per-
formed RNA-seq betweenHepG2.2.15-CD36OE cells and HepG2.2.15-vector cells and identi-
fied 141 DEGs. The present study results provide significant clues for future studies and extend
our knowledge regarding the synergistic effect of genes related to CD36 overexpression in an
HBV replication background. Given the fact that CD36 increases HBV replication to a certain
level, we speculate that for those HBV infected patients with a higher expression level of CD36,
such as NAFLD and MS, proper control of CD36 or metabolism treatment may serve as an
adjunctive therapeutic means which may have an additive effect to the conventional anti-viral
drugs such as interferon and reverse-transcriptase inhibitors.
Supporting Information
S1 Fig. The expression of CD36 in HepG2 and HepG2.2.15 cells.
(TIF)
S2 Fig. Boxplot of the log transformedRPKM expression values across six transcripts.
(TIF)
S1 Table. Primers for quantitative real-timePCR.
(DOC)
S2 Table. Statistical results of quality control in the transcription group of all samples.
(XLSX)





Formal analysis: JH LZ.
Funding acquisition: YC XZR.






Writing – original draft: JH YC.
Writing – review& editing: JH YC XZR.
The Relationship between Fatty Acid Translocase CD36 and the Hepatitis B Virus
PLOS ONE | DOI:10.1371/journal.pone.0164787 October 17, 2016 12 / 15
References
1. Geng X, Huang C, Qin Y, McCombs JE, Yuan Q, Harry BL, et al. Hepatitis B virus X protein targets
Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction.
Proceedings of the National Academy of Sciences of the United States of America. 2012; 109
(45):18471–6. doi: 10.1073/pnas.1204668109 PMID: 23091012; PubMed Central PMCID:
PMC3494919.
2. Bar-Yishay I, Shaul Y, Shlomai A. Hepatocyte metabolic signalling pathways and regulation of hepatitis
B virus expression. Liver international: official journal of the International Association for the Study of
the Liver. 2011; 31(3):282–90. doi: 10.1111/j.1478-3231.2010.02423.x PMID: 21281428.
3. Shlomai A, Shaul Y. The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an
effective anti-viral weapon. Medical hypotheses. 2008; 71(1):53–7. doi: 10.1016/j.mehy.2007.08.032
PMID: 18334285.
4. Park YM. CD36, a scavenger receptor implicated in atherosclerosis. Experimental & molecular medi-
cine. 2014; 46:e99. doi: 10.1038/emm.2014.38 PMID: 24903227; PubMed Central PMCID:
PMC4081553.
5. Pepino MY, Kuda O, Samovski D, Abumrad NA. Structure-function of CD36 and importance of fatty
acid signal transduction in fat metabolism. Annual review of nutrition. 2014; 34:281–303. doi: 10.1146/
annurev-nutr-071812-161220 PMID: 24850384; PubMed Central PMCID: PMC4329921.
6. Nergiz-Unal R, Rademakers T, Cosemans JM, Heemskerk JW. CD36 as a multiple-ligand signaling
receptor in atherothrombosis. Cardiovascular & hematological agents in medicinal chemistry. 2011; 9
(1):42–55. PMID: 20939828.
7. Cheng JJ, Li JR, Huang MH, Ma LL, Wu ZY, Jiang CC, et al. CD36 is a co-receptor for hepatitis C virus
E1 protein attachment. Scientific reports. 2016; 6:21808. doi: 10.1038/srep21808 PMID: 26898231;
PubMed Central PMCID: PMC4761891.
8. Berre S, Gaudin R, Cunha de Alencar B, Desdouits M, Chabaud M, Naffakh N, et al. CD36-specific
antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells.
The Journal of experimental medicine. 2013; 210(12):2523–38. doi: 10.1084/jem.20130566 PMID:
24145510; PubMed Central PMCID: PMC3832921.
9. Miquilena-Colina ME, Lima-Cabello E, Sanchez-Campos S, Garcia-Mediavilla MV, Fernandez-Ber-
mejo M, Lozano-Rodriguez T, et al. Hepatic fatty acid translocase CD36 upregulation is associated
with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and
chronic hepatitis C. Gut. 2011; 60(10):1394–402. doi: 10.1136/gut.2010.222844 PMID: 21270117.
10. Handberg A, Norberg M, Stenlund H, Hallmans G, Attermann J, Eriksson JW. Soluble CD36 (sCD36)
clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabe-
tes risk. The Journal of clinical endocrinology and metabolism. 2010; 95(4):1939–46. doi: 10.1210/jc.
2009-2002 PMID: 20139232.
11. Jarcuska P, Janicko M, Kruzliak P, Novak M, Veseliny E, Fedacko J, et al. Hepatitis B virus infection in
patients with metabolic syndrome: a complicated relationship. Results of a population based study.
European journal of internal medicine. 2014; 25(3):286–91. doi: 10.1016/j.ejim.2014.01.006 PMID:
24445023.
12. Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with
cloned hepatitis B virus DNA. Proceedings of the National Academy of Sciences of the United States
of America. 1987; 84(4):1005–9. PMID: 3029758; PubMed Central PMCID: PMC304350.
13. Ren JH, Tao Y, Zhang ZZ, Chen WX, Cai XF, Chen K, et al. Sirtuin 1 regulates hepatitis B virus tran-
scription and replication by targeting transcription factor AP-1. Journal of virology. 2014; 88(5):2442–
51. doi: 10.1128/JVI.02861-13 PMID: 24335313; PubMed Central PMCID: PMC3958108.
14. Wang K, Singh D, Zeng Z, Coleman SJ, Huang Y, Savich GL, et al. MapSplice: accurate mapping of
RNA-seq reads for splice junction discovery. Nucleic acids research. 2010; 38(18):e178. doi: 10.1093/
nar/gkq622 PMID: 20802226; PubMed Central PMCID: PMC2952873.
15. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian tran-
scriptomes by RNA-Seq. Nature methods. 2008; 5(7):621–8. doi: 10.1038/nmeth.1226 PMID:
18516045.
16. Audic S, Claverie JM. The significance of digital gene expression profiles. Genome research. 1997; 7
(10):986–95. PMID: 9331369.
17. Boyle EI, Weng S, Gollub J, Jin H, Botstein D, Cherry JM, et al. GO::TermFinder—open source soft-
ware for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms
associated with a list of genes. Bioinformatics. 2004; 20(18):3710–5. doi: 10.1093/bioinformatics/
bth456 PMID: 15297299; PubMed Central PMCID: PMC3037731.
The Relationship between Fatty Acid Translocase CD36 and the Hepatitis B Virus
PLOS ONE | DOI:10.1371/journal.pone.0164787 October 17, 2016 13 / 15
18. Aoki-Kinoshita KF, Kanehisa M. Gene annotation and pathway mapping in KEGG. Methods in molecu-
lar biology. 2007; 396:71–91. doi: 10.1007/978-1-59745-515-2_6 PMID: 18025687.
19. Ouyang Y, Guo J, Lin C, Lin J, Cao Y, Zhang Y, et al. Transcriptomic analysis of the effects of Toll-like
receptor 4 and its ligands on the gene expression network of hepatic stellate cells. Fibrogenesis & tis-
sue repair. 2016; 9:2. doi: 10.1186/s13069-016-0039-z PMID: 26900402; PubMed Central PMCID:
PMC4759739.
20. Prieto C, Risueno A, Fontanillo C, De las Rivas J. Human gene coexpression landscape: confident net-
work derived from tissue transcriptomic profiles. PloS one. 2008; 3(12):e3911. doi: 10.1371/journal.
pone.0003911 PMID: 19081792; PubMed Central PMCID: PMC2597745.
21. Lin ZW, Gu J, Liu RH, Liu XM, Xu FK, Zhao GY, et al. Genome-wide screening and co-expression net-
work analysis identify recurrence-specific biomarkers of esophageal squamous cell carcinoma.
Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine.
2014; 35(11):10959–68. doi: 10.1007/s13277-014-2388-9 PMID: 25087095.
22. Zhang Z, Sun ZZ, Xiao X, Zhou S, Wang XC, Gu J, et al. Mechanism of BDE209-induced impaired glu-
cose homeostasis based on gene microarray analysis of adult rat liver. Archives of toxicology. 2013;
87(8):1557–67. doi: 10.1007/s00204-013-1059-8 PMID: 23640034.
23. Zhang T, Cai J, Chang J, Yu D, Wu C, Yan T, et al. Evidence of associations of APOBEC3B gene dele-
tion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Human molecular
genetics. 2013; 22(6):1262–9. doi: 10.1093/hmg/dds513 PMID: 23213177.
24. Ghosh M, Shen Z, Schaefer TM, Fahey JV, Gupta P, Wira CR. CCL20/MIP3alpha is a novel anti-HIV-1
molecule of the human female reproductive tract. American journal of reproductive immunology. 2009;
62(1):60–71. doi: 10.1111/j.1600-0897.2009.00713.x PMID: 19527233; PubMed Central PMCID:
PMC3837341.
25. Guth CA, Sodroski J. Contribution of PDZD8 to stabilization of the human immunodeficiency virus type
1 capsid. Journal of virology. 2014; 88(9):4612–23. doi: 10.1128/JVI.02945-13 PMID: 24554657;
PubMed Central PMCID: PMC3993830.
26. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, et al. Genome-scale RNAi screen for host
factors required for HIV replication. Cell host & microbe. 2008; 4(5):495–504. doi: 10.1016/j.chom.
2008.10.004 PMID: 18976975.
27. Landry DM, Hertz MI, Thompson SR. RPS25 is essential for translation initiation by the Dicistroviridae
and hepatitis C viral IRESs. Genes & development. 2009; 23(23):2753–64. doi: 10.1101/gad.1832209
PMID: 19952110; PubMed Central PMCID: PMC2788332.
28. Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, et al. Gene expression profiling of human HBV-
and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. International
journal of oncology. 2006; 29(2):315–27. PMID: 16820872.
29. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, et al. Functional organization of
the transcriptome in human brain. Nature neuroscience. 2008; 11(11):1271–82. doi: 10.1038/nn.2207
PMID: 18849986; PubMed Central PMCID: PMC2756411.
30. Suspene R, Guetard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP. Extensive editing of both
hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proceedings of
the National Academy of Sciences of the United States of America. 2005; 102(23):8321–6. doi: 10.
1073/pnas.0408223102 PMID: 15919829; PubMed Central PMCID: PMC1149401.
31. Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, et al. Specific and nonhepatotoxic degra-
dation of nuclear hepatitis B virus cccDNA. Science. 2014; 343(6176):1221–8. doi: 10.1126/science.
1243462 PMID: 24557838.
32. Lucifora J, Protzer U. Attacking hepatitis B virus cccDNA—The holy grail to hepatitis B cure. Journal of
hepatology. 2016; 64(1 Suppl):S41–8. doi: 10.1016/j.jhep.2016.02.009 PMID: 27084036.
33. Bonvin M, Greeve J. Effects of point mutations in the cytidine deaminase domains of APOBEC3B on
replication and hypermutation of hepatitis B virus in vitro. The Journal of general virology. 2007; 88(Pt
12):3270–4. doi: 10.1099/vir.0.83149-0 PMID: 18024895.
34. Kuda O, Jenkins CM, Skinner JR, Moon SH, Su X, Gross RW, et al. CD36 protein is involved in store-
operated calcium flux, phospholipase A2 activation, and production of prostaglandin E2. The Journal
of biological chemistry. 2011; 286(20):17785–95. doi: 10.1074/jbc.M111.232975 PMID: 21454644;
PubMed Central PMCID: PMC3093854.
35. Hoffman L, Chandrasekar A, Wang X, Putkey JA, Waxham MN. Neurogranin alters the structure and
calcium binding properties of calmodulin. The Journal of biological chemistry. 2014; 289(21):14644–
55. doi: 10.1074/jbc.M114.560656 PMID: 24713697; PubMed Central PMCID: PMC4031520.
36. Bouchard MJ, Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA repli-
cation. Science. 2001; 294(5550):2376–8. doi: 10.1126/science.294.5550.2376 PMID: 11743208.
The Relationship between Fatty Acid Translocase CD36 and the Hepatitis B Virus
PLOS ONE | DOI:10.1371/journal.pone.0164787 October 17, 2016 14 / 15
37. Bouchard MJ, Puro RJ, Wang L, Schneider RJ. Activation and inhibition of cellular calcium and tyrosine
kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication.
Journal of virology. 2003; 77(14):7713–9. PMID: 12829810; PubMed Central PMCID: PMC161925.
doi: 10.1128/JVI.77.14.7713-7719.2003
38. Choi Y, Gyoo Park S, Yoo JH, Jung G. Calcium ions affect the hepatitis B virus core assembly. Virol-
ogy. 2005; 332(1):454–63. doi: 10.1016/j.virol.2004.11.019 PMID: 15661175.
39. Yang B, Bouchard MJ. The hepatitis B virus X protein elevates cytosolic calcium signals by modulating
mitochondrial calcium uptake. Journal of virology. 2012; 86(1):313–27. doi: 10.1128/JVI.06442-11
PMID: 22031934; PubMed Central PMCID: PMC3255901.
40. Zhang C, Wang L, Thomas S, Wang K, Lin DH, Rinehart J, et al. Src family protein tyrosine kinase reg-
ulates the basolateral K channel in the distal convoluted tubule (DCT) by phosphorylation of KCNJ10
protein. The Journal of biological chemistry. 2013; 288(36):26135–46. doi: 10.1074/jbc.M113.478453
PMID: 23873931; PubMed Central PMCID: PMC3764816.
41. Dong YY, Pike AC, Mackenzie A, McClenaghan C, Aryal P, Dong L, et al. K2P channel gating mecha-
nisms revealed by structures of TREK-2 and a complex with Prozac. Science. 2015; 347(6227):1256–
9. doi: 10.1126/science.1261512 PMID: 25766236.
The Relationship between Fatty Acid Translocase CD36 and the Hepatitis B Virus
PLOS ONE | DOI:10.1371/journal.pone.0164787 October 17, 2016 15 / 15
